- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| CANNARA BIOTECH Aktie jetzt für 0€ handeln | |||||
| 22.07. | Cannara Biotech Inc (2): Cannara gets OK from TSX for NCIB | 1 | Stockwatch | ||
| 22.07. | Cannara Biotech Inc.: Cannara Announces Normal Course Issuer Bid | 2 | GlobeNewswire (USA) | ||
| 15.07. | Cannara Q3 2026 slides: revenue climbs 16% as cash flow drops | 2 | Investing.com | ||
| 15.07. | Cannara Biotech Reports Q3 2026 Results: Full Earnings Call Transcript | 1 | Benzinga.com | ||
| 15.07. | Cannara Biotech Inc.: Cannara Reports Record Q3 Revenues and Continued Profitability Accompanied By Expanding National Distribution and Accelerated Capacity Expansion | 305 | GlobeNewswire (Europe) | Delivered strong Q3 financial results: Generated $31.8 million in total net revenues, $13.4 million in gross profit before fair value adjustments, or 42% of revenues, $8.5 million in adjusted EBITDA1... ► Artikel lesen | |
| 15.07. | Cannara Biotech reports Q3 results | 3 | Seeking Alpha | ||
| 15.07. | Cannara Biotech Inc (2): Cannara Biotech, Curaleaf sign supply agreement | 2 | Stockwatch | ||
| 15.07. | Curaleaf Holdings Inc (2): Cannara Biotech, Curaleaf sign supply agreement | 2 | Stockwatch | ||
| 14.07. | Stocks in Play: Cannara Biotech Inc. | 1 | Baystreet.ca | ||
| 08.07. | Cannara Biotech Inc (2): Cannara Biotech to release Q3 results on July 15 | 1 | Stockwatch | ||
| 02.07. | Cannara Biotech Inc (2): Cannara obtains Canadian rights to Ampersand technology | 1 | Stockwatch | ||
| 02.07. | Cannara Biotech Inc.: Cannara Secures Exclusive Canadian Rights to Blue River's Ampersand Live Rosin Infusion Technology | 613 | GlobeNewswire (Europe) | MONTREAL, July 02, 2026 (GLOBE NEWSWIRE) -- Cannara Biotech Inc. ("Cannara", the "Company", "us" or "we") (TSX: LOVE) (OTCQX: LOVFF) (FRA: 8CB0), a vertically integrated producer of premium-grade... ► Artikel lesen | |
| 07.05. | Cannara Biotech Inc (2): Cannara Biotech closes Medican Organic acquisition | 1 | Stockwatch | ||
| 14.04. | Cannara Biotech GAAP EPS of $0.02, revenue of $27.1M | 1 | Seeking Alpha | ||
| 14.04. | Cannara Biotech Inc.: Cannara Reports Q2 Fiscal 2026 Results with Continued Profitability, Strong Operating Cash Flow and #1 Retail Market Share in Québec | 362 | GlobeNewswire (Europe) | Delivered strong Q2 financial results: Generated $27.2 million in total net revenues, $11.6 million in gross profit before fair value adjustments or 43% of revenues, $6.0 million in adjusted EBITDA1... ► Artikel lesen | |
| 07.04. | Cannara Biotech Inc (2): Cannara Biotech to release fiscal Q2 results April 14 | 1 | Stockwatch | ||
| 07.04. | Stocks in Play: Cannara Biotech Inc. | 1 | Baystreet.ca | ||
| 19.03. | CEO Clips: Video - CEO Clips: Cannara Biotech Graduates to Toronto Stock Exchange | 412 | Newsfile | Vancouver, British Columbia--(Newsfile Corp. - March 19, 2026) - Cannara Biotech Inc. (TSX: LOVE) (OTCQX: LOVFF) (FSE: 8CB0) is a vertically integrated producer of affordable premium-grade cannabis... ► Artikel lesen | |
| 17.03. | Toronto Stock Exchange: Cannara Biotech Inc. (LOVE) Opens the Market | 478 | Newsfile | Toronto, Ontario--(Newsfile Corp. - March 17, 2026) - Donald Olds, Lead Director and Chairman of the Audit and Governance Committee, Cannara Biotech Inc. ("Cannara" or the "Company") (TSX: LOVE)... ► Artikel lesen | |
| 27.02. | Cannara Biotech Inc (2): Cannara receives final OK to transfer shares to TSX | 1 | Stockwatch |
1 2 Weiter >>
31 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 40,970 | -0,06 % | Märkte am Morgen: Öl, Bilanzen der Wochen, Palantir, Novo Nordisk/Eli Lilly, Microsoft/Amazon, BYD | Der DAX hat sich in der vergangenen Woche gut geschlagen. Unter dem Strich legte er 2,1 Prozent zu. Am Freitag näherte er sich kurzzeitig seinem Rekordhoch, gab den größten Teil seiner Gewinne allerdings... ► Artikel lesen | |
| AURORA CANNABIS | 2,598 | +0,93 % | Aurora Cannabis Inc.: Aurora Cannabis Announces Fiscal 2027 First Quarter Results | NASDAQ | TSX: ACB
Delivers Net Revenue of $67.6 million, including a 17% YoY Increase in International Medical Cannabis Net Revenue
Safari Flower Company Receives Three-Year EU-GMP... ► Artikel lesen | |
| CANOPY GROWTH | 0,841 | -0,10 % | Why Rescheduling Might Not Move Canopy Growth's Stock as Much as You Think | ||
| STADA ARZNEIMITTEL | - | - | Stada startet neue Kampagne für Elotrans Reload | ||
| TILRAY BRANDS | 3,955 | +0,13 % | Tilray-Aktie: Startet jetzt die 700%-Chance? | Die Tilray-Aktie hat in den vergangenen Tagen eine bemerkenswerte Kehrtwende vollzogen. Nach enttäuschenden Quartalszahlen am 28. Juli geriet der Cannabis-Titel zunächst unter Druck, ehe bereits einen... ► Artikel lesen | |
| INNOCAN PHARMA | 1,500 | +0,67 % | Innocan Pharma Corporation: Over 100,000 Positive Verified Customer Reviews Reflect Growing Consumer Trust | Milestone underscores strong consumer confidence, exceptional product quality, and the Company's expanding presence in the U.S. consumer wellness marketHERZLIYA, Israel and CALGARY, Alberta... ► Artikel lesen | |
| CRONOS GROUP | 2,646 | -1,19 % | Cronos Group Inc.: Cronos Group Reports 2026 Second Quarter Results | Organically achieved record net revenue, gross profit, and Adjusted EBITDA while reducing share count Net revenue in Q2 2026 increased by 51% year-over-year on an organic, constant-currency basis... ► Artikel lesen | |
| SYNBIOTIC | 1,106 | +2,98 % | EQS-Adhoc: SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung von Insolvenzverfahren zu stellen | EQS-Ad-hoc: SYNBIOTIC SE / Schlagwort(e): Strategische Unternehmensentscheidung/Insolvenz
SYNBIOTIC SE: SOLIDMIND Group GmbH und Lean Labs Pharma GmbH beabsichtigen, Anträge auf Eröffnung... ► Artikel lesen | |
| DIGICANN VENTURES | 0,012 | +118,18 % | XFRA VY3: WIEDERAUFNAHME/RESUMPTION | FOLGENDE(S) INSTRUMENT(E) WIRD/ WERDEN WIEDER IN DEN HANDEL AUFGENOMMEN MIT FOLGENDEM TRADING SCHEDULE.THE FOLLOWING INSTRUMENT(S) IS/ARE RESUMED TRADING WITH FOLLOWING TRADING SCHEDULE:INSTRUMENT NAME... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 0,864 | +1,77 % | Organigram Global Inc: Organigram Global to release fiscal Q3 results Aug. 11 | ||
| GREEN THUMB INDUSTRIES | 5,870 | -1,68 % | Green Thumb Industries Reports Second Quarter 2026 Results | CHICAGO and VANCOUVER, British Columbia, Aug. 04, 2026 (GLOBE NEWSWIRE) -- Green Thumb Industries Inc. ("Green Thumb" or the "Company") (CSE: GTII) (OTCQX: GTBIF), a leading national cannabis consumer... ► Artikel lesen | |
| SNDL | 1,057 | -0,19 % | SNDL: Produktionsstätte in New Brunswick besteht EU-GMP-Audit | ||
| CRESCO LABS | 0,621 | -3,72 % | Cresco Labs Q2 2026 slides: cannabis re-rating thesis meets skepticism | ||
| NOVERIS HEALTH SCIENCES | 0,292 | -9,88 % | Noveris Health Sciences Inc.: Noveris Health Sciences Inc. Unaware of Any Material Change | Vancouver, British Columbia--(Newsfile Corp. - August 6, 2026) - At the request of CIRO, Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") wishes... ► Artikel lesen | |
| QUANTUM BIOPHARMA | 2,912 | +12,35 % | Quantum BioPharma Announces Closing of Debt Settlement | THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. TORONTO, July 30, 2026... ► Artikel lesen |
Das Unternehmen CANNARA BIOTECH INC kann der Branche Pharma zugeordnet werden. Die relative Kursveränderung beträgt aktuell 0,00 % bei einem Aktienkurs von 1,130 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu CANNARA BIOTECH INC finden Sie auf Wallstreet Online.